The Delhi High Court in India Has Issued an Injunction, Restraining Sinopharm Weiqida from Exporting Its “Amoxycillin Trihydrate” Product to India, as It Infringes the Patent of Centrient Pharmaceuticals
ROTTERDAM, the Netherlands, Feb. 19 (Korea Bizwire) — Centrient Pharmaceuticals (“Centrient”), the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and anti-fungals, announced that the Delhi High Court in India has granted an injunction against Sinopharm Weiqida Pharmaceuticals and Sinopharm India, restricting the export and/or import into India of its active [...]







